Report quantifies shrinking Asian IPMI market during Covid
Despite a first-ever market decline, new international private medical insurance (IPMI) markets are emerging post-Covid, IPMI advisor McGrigor Group revealed in its three new market reports
In ‘IPMI: China, Hong Kong and Singapore, 2017-2025’, for the first time ever, the three major markets that make up over 60 per cent of Asia’s IPMI market are reviewed over 70 pages and 45 tables. ‘10 New Key Player Profiles’ looks at 10 under-the-wire key IPMI players across 45 pages with new financial data revealed for the first time.
Meanwhile, in ‘Global Market Size & Trends Update, 2019-2025’, McGrigor Group give a detailed overview of each main region in the IPMI market from 2019 through the two Covid years to end 2021 and then forecasts out to 2025.
The Asian market for international private medical insurance is set to decline in terms of fewer resident expats and increased price sensitivity. However, the report forecasts longer term growth, especially from the growing middle classes. A potentially massive new segment is now apparent.
James McGrigor, CEO of McGrigor, commented: “The objective is to provide key stakeholders in the industry (brokers, payers, investors and health service companies) with real insight by providing an overview of the world, and each region with a drill-down into the size and trends of multiple target customer segments, competitiveness, growth and profitability drivers and hence a forecast for the next four years.”